Hypertrophic pulmonary osteoarthropathy as the presenting symptom of non-small cell lung cancer: A case report
Author(s) -
Nguyen Sheila,
Hojjati Mehrnaz
Publication year - 2014
Publication title -
journal of cancer research and experimental oncology
Language(s) - English
Resource type - Journals
ISSN - 2141-2243
DOI - 10.5897/jcreo11.042
Subject(s) - medicine , hypertrophic osteoarthropathy , octreotide , rash , lung cancer , chemotherapy , lung , disease , dermatology , small cell lung carcinoma , small cell carcinoma , surgery , oncology , somatostatin
Hypertrophic pulmonary osteoarthropathy (HOA) is a disabling condition that may occur secondarily to primary lung carcinoma. Management of joint pain in patients with HOA is challenging, and treatment options are experimental. Here we report an unusual case of HOA in a 54 year-old man who presented with fever, rash and arthralgia as initial symptoms of an underlying non-small cell lung cancer. He did not respond to various treatment modalities including non-steroidal anti-inflammatory drugs (NSAIDs), pamidronate, and octreotide. His pain symptoms only improved once chemotherapy was administered. This case exemplifies the diagnostic and therapeutic challenge in patients with HOA, and underlines the need for further research to better define this disease and appropriately direct therapy. Key words: Osteoarthropathy, secondary hypertrophic; carcinoma, non-small-cell lung; therapy; pamidronate; octreotide.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom